Dr. Dina Radenkovic, CEO of Gameto, discusses the use of iPSCs in fertility treatments, the most significant scientific hurdles they've encountered in developing and scaling these therapies ...
Menopause, driven by ovarian aging and the depletion of ovarian reserves, marks the end of a woman's fertility, and while many aspects of these processes are well understood, the overall dynamics ...
The research team has developed a theoretical framework that quantitatively predicts menopause timing. By analyzing how ovarian follicles transition through different stages, the researchers' model ...
In a study published in a 2024 issue of the American Journal of Obstetrics & Gynecology, researchers predicted that for most ...
News-Medical.Net on MSN2d
Platelet-rich plasma may enhance ovarian rejuvenation and improve egg quality in womenA new research paper was published in Aging (Aging-US) on February 18, 2025, Volume 17, Issue 2, titled "Transcriptomic ...
A new research paper was published in Aging (Aging-US ... cumulus cells from patients <38 years old with a history of poor ovarian response (POR) treated with platelet-rich plasma (PRP)." ...
scientists may develop targeted fertility therapies to support women facing infertility due to diminished ovarian reserve. The journal Aging aims to promote 1) treatment of age-related diseases by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback